Genmab A/S
NASDAQ:GMAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
NASDAQ:GMAB
|
DK |
|
F
|
FG Merger II Corp
NASDAQ:FGMC
|
US |
|
Viatris Inc
NASDAQ:VTRS
|
US |
|
K
|
Kerry Express (Thailand) PCL
SET:KEX
|
TH |
|
Kingsoft Cloud Holdings Ltd
NASDAQ:KC
|
CN |
|
AGNC Investment Corp
NASDAQ:AGNC
|
US |
|
D
|
Doxa AB
STO:DOXA
|
SE |
|
W
|
Walmart Inc
XHAM:WMT
|
US |
|
Arafura Resources Ltd
ASX:ARU
|
AU |
|
bluebird bio Inc
NASDAQ:BLUE
|
US |
|
Planet Fitness Inc
NYSE:PLNT
|
US |
|
Sysmex Corp
TSE:6869
|
JP |
|
Evolv Technologies Holdings Inc
NASDAQ:EVLV
|
US |
|
Ashoka Buildcon Ltd
NSE:ASHOKA
|
IN |
|
Sprinklr Inc
NYSE:CXM
|
US |
|
RFA Financial Inc
TSX:RFA
|
CA |
|
G
|
Gr Sarantis SA
ATHEX:SAR
|
GR |
|
Verastem Inc
NASDAQ:VSTM
|
US |
|
C
|
Credit Agricole SA
SWB:XCA
|
FR |
|
Ford Otomotiv Sanayi AS
IST:FROTO.E
|
TR |
Wall St Price Targets
GMAB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for GMAB is 36.13 USD with a low forecast of 20.85 USD and a high forecast of 50.03 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GMAB's stock price target?
Price Target
36.13
USD
According to Wall Street analysts, the average 1-year price target for GMAB is 36.13 USD with a low forecast of 20.85 USD and a high forecast of 50.03 USD.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.
